<DOC>
	<DOCNO>NCT02564770</DOCNO>
	<brief_summary>This cross-sectional , observational study examine factor lead therapeutic decision use MabThera ( rituximab ) participant RA . Routine rheumatology clinical practice data participant treat rituximab RA collect analysed chart review .</brief_summary>
	<brief_title>A Retrospective Chart Review MabThera ( Rituximab ) Treatment Rheumatoid Arthritis ( RA ) Participants Australia</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Greater equal ( &gt; = ) 18 year age time data collection RA diagnose rheumatologist Treatment rituximab RA Participants whose primary diagnosis indication rituximab treatment condition RA Participants treat experimental agent RA currently approve treatment RA Australia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>